This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0448U only for oncoReveal™ DX Lung and Colon Cancer Assay from Pillar® Biosciences. The test uses next–generation sequencing to detect mutations in DNA derived from formalin–fixed paraffin–embedded (FFPE) lung cancer and colon cancer tumor tissue. Specifically, the test looks for single–nucleotide variants and deletions in the EGFR and KRAS genes. The test result is reported as the presence or absence of one or more targeted mutations and includes recommended therapeutic options.
For clinical responsibility, terminology, tips and additional info
start codify free trial.